Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung Cancer

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 23, 2024

Primary Completion Date

October 20, 2027

Study Completion Date

December 30, 2027

Conditions

HCC - Hepatocellular CarcinomaNSCLC (Advanced Non-small Cell Lung Cancer)

Interventions

BIOLOGICAL

Universal CAR-T cells injection for treating HCC and NSCLC

A novel universal CAR-T platform to treat cancer patients

Trial Locations (1)

RECRUITING

First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

All Listed Sponsors

lead

Wondercel Biotech (ShenZhen)

INDUSTRY